www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

   

Manufacturers subject to latest drug recall rules

By Shan Juan (China Daily)
Updated: 2007-12-13 07:42

The State Food and Drug Administration (SFA) Wednesday announced a new provision that obliges all manufacturers of imported drugs to provide Chinese authorities with full details of product recalls in a bid to avoid potential health hazards.

The Provisions for Drug Recall, the country's first nationwide regulation on the issue, states that drug manufacturers at home and abroad should be the first to be held accountable for the safety and quality of the drugs they sell, SFDA spokeswoman Yan Jiangying said at its regular monthly press briefing.

The provision states that drugs found to be potentially hazardous should be recalled voluntarily by producers, while those that are found to be fake or of substandard quality will be dealt with under the terms of the Drug Administration Law.

The provision stipulates that recalls are divided into three categories based on different risk levels.

These range from 24 hours for drugs that may cause serious damage to human health, to 72 hours for those deemed non-life-threatening.

Once the hazardous products have been recalled, producers must immediately inform distributors and medical institutions to stop using or selling the drugs.

The manufacturers involved will also have to report the recalls to the drug administration.

"We hope governments and companies can cooperate to enhance and refine the establishment of the recall system to safeguard drug safety and public health," Yan said.

The provision also states that penalties or liabilities for companies that voluntarily recall hazardous drugs will be eased or excused.

Conversely, manufacturers that fail, for whatever reason, to recall hazardous drugs will be subject to compulsory recalls by the authorities if deemed necessary. Such firms will also be fined three times the value of the recalled drugs.

To realize and facilitate adequate drug recalls, producers should also put in place surveillance systems to monitor and look out for potentially harmful products, the SFDA said.

"Drug manufacturers cannot merely rely on government information.

"They should, out of a sense of social responsibility, make efforts to monitor potential adverse reactions to their products," Yan said.

Distributors and medical institutions must also inform the authorities and producers of any safety risks associated with a particular drug, the provision says.

"The involvement of the general public, especially drug distributors and users, is extremely important given the fact that a pilot scheme of drug recalls in Wuhan, capital of Hubei Province, showed that the recalls were imposed in most cases," Yan said.



Top China News  
Today's Top News  
Most Commented/Read Stories in 48 Hours
主站蜘蛛池模板: 国产精品免费观看视频播放 | 92看片淫黄大片一级 | 在线观看一二三区 | 亚洲高清一区二区三区久久 | 色老头久久久久 | 欧美观看一级毛片 | 日韩亚洲一区中文字幕在线 | 男操女视频网站 | 国产精品免费久久 | 国产亚洲精品自在久久77 | 国产精品成人免费观看 | 久草资源网 | 一区二区在线欧美日韩中文 | 欧美一级va在线视频免费播放 | 亚洲欧美精品网站在线观看 | 亚洲天堂美女视频 | 亚洲成人免费观看 | 欧美一级xxxx俄罗斯一级 | 成年免费大片黄在线观看一 | 高清波多野结衣一区二区三区 | 三级黄色片网站 | 99久免费精品视频在线观看2 | 成人毛片免费 | 在线看片日韩 | 不卡午夜视频 | 久久精品在现线观看免费15 | 精品久久久久久国产免费了 | 亚洲免费一区 | 国产午夜人做人视频羞羞 | 国产成人精品午夜 | 黄 色 三 片 | 久久婷婷影院 | 精品真实国产乱文在线 | 亚洲视频一| 久久93精品国产91久久综合 | 国产精品久久久精品三级 | 日韩在线手机看片免费看 | 亚洲一级成人 | 在线视频一区二区三区四区 | 久草视频手机在线观看 | 中文无线乱码二三四区 |